|
HS Code |
427886 |
| Generic Name | Doxycycline |
| Drug Class | Tetracycline antibiotic |
| Brand Names | Vibramycin, Doryx, Monodox, Oracea |
| Route Of Administration | Oral, intravenous |
| Mechanism Of Action | Inhibits bacterial protein synthesis by binding to the 30S ribosomal subunit |
| Indications | Bacterial infections, acne, malaria prophylaxis, Lyme disease, respiratory tract infections |
| Common Side Effects | Nausea, diarrhea, photosensitivity, abdominal pain |
| Contraindications | Hypersensitivity to tetracyclines, pregnancy, children under 8 years |
| Pregnancy Category | Category D (risk) |
| Half Life | 16-22 hours |
| Metabolism | Minimal hepatic metabolism |
| Excretion | Primarily fecal, some renal |
| Storage Conditions | Store at room temperature, away from light and moisture |
As an accredited Doxycycline factory, we enforce strict quality protocols—every batch undergoes rigorous testing to ensure consistent efficacy and safety standards.
| Packing | Doxycycline packaging typically includes a white plastic bottle containing 100 tablets, clearly labeled with dosage, manufacturer, and safety information. |
| Shipping | Doxycycline is typically shipped in tightly sealed, moisture-resistant containers to protect it from light and humidity. The packaging is clearly labeled with hazard and handling information. During transit, standard temperature conditions are maintained unless otherwise specified, and all shipments comply with regulatory requirements for pharmaceuticals and chemical safety. |
| Storage | Doxycycline should be stored in a tightly closed container at a temperature below 30°C (86°F), away from light, moisture, and heat. It should not be frozen. Store separately from incompatible substances, such as strong acids and oxidizers. Keep out of reach of children and ensure proper labeling to prevent accidental misuse or exposure. Dispose of expired medication properly. |
|
Purity 98%: Doxycycline Purity 98% is used in pharmaceutical manufacturing, where it ensures high therapeutic efficacy and consistent dosage formulation. Molecular weight 444.43 g/mol: Doxycycline Molecular weight 444.43 g/mol is used in injectable antibiotic solutions, where it facilitates accurate mass-based dosing and predictable pharmacokinetics. Solubility 50 mg/mL (in water): Doxycycline Solubility 50 mg/mL (in water) is used in oral suspension formulations, where it enables rapid drug dissolution and enhanced bioavailability. Stability temperature 25°C: Doxycycline Stability temperature 25°C is used in room-temperature storage packaging, where it maintains active ingredient potency and prolongs shelf life. Particle size D90 <10 µm: Doxycycline Particle size D90 <10 µm is used in tablet compaction processes, where it promotes uniform blending and optimizes tablet dissolution rates. Melting point 201-202°C: Doxycycline Melting point 201-202°C is used in hot-melt extrusion applications, where it prevents degradation during processing and supports stable drug incorporation. pH stability 1.5–7.5: Doxycycline pH stability 1.5–7.5 is used in gastrointestinal delivery systems, where it preserves drug integrity across varying gastric conditions and enhances patient outcomes. Shelf life 36 months: Doxycycline Shelf life 36 months is used in global supply chain distribution, where it sustains product quality and reduces the risk of expiration-related losses. Assay ≥98.0%: Doxycycline Assay ≥98.0% is used in regulatory-approved medicinal formulations, where it assures compliance with pharmacopeial standards and reliable patient efficacy. Impurity content ≤1.0%: Doxycycline Impurity content ≤1.0% is used in high-purity drug batches, where it minimizes adverse reactions and improves overall product safety. |
Competitive Doxycycline prices that fit your budget—flexible terms and customized quotes for every order.
For samples, pricing, or more information, please call us at +8615371019725 or mail to admin@sinochem-nanjing.com.
We will respond to you as soon as possible.
Tel: +8615371019725
Email: admin@sinochem-nanjing.com
Flexible payment, competitive price, premium service - Inquire now!
Doxycycline stands out in the world of antibiotics because it has earned a reputation not just for versatility but for reliability. Doctors and pharmacists often rely on it to tackle a wide range of infections. From fighting off lingering respiratory bugs to stepping up against more stubborn illnesses like Lyme disease, this medication has found a regular spot in clinics and pharmacies worldwide. Its use often extends into both urban hospitals and rural clinics, something you notice once you start talking to healthcare professionals about their daily toolbox.
Most people recognize doxycycline in the form of oral tablets, usually in dosages of 100 mg, but it doesn’t just come as pills—capsules and even suspension formulations give doctors and patients some flexibility. Infectious disease specialists, for example, often point to these different forms as a clear advantage when a patient struggles to swallow or absorb regular tablets. Doxycycline’s adaptability in dosing and form helps it serve a broad age group, from teens dealing with stubborn acne to adults traveling abroad who need protection against malaria.
Many antibiotics show up to do a single specific job, and some struggle as bacteria grow wise to them. Doxycycline seems to have a broader resume. It belongs to the tetracycline class, known for blocking bacterial protein production—you don’t have to be a microbiologist to appreciate how fundamental that is. Unlike penicillin, which cracks open bacterial cell walls, doxycycline slips inside and prevents the bug from multiplying in the first place. This approach means it can tackle organisms that other medicines miss, especially when bacteria have figured out how to dodge older drugs.
Doctors often reach for doxycycline when patients deal with atypical pneumonia or mysterious tick bites. Its broad coverage protects against a host of bacterial species, including some that have shrugged off other antibiotics. For those dealing with acne, the anti-inflammatory actions matter as much as its antibacterial punch. Dermatologists see real-life results on the clinic floor, and most patients describe clear improvements without the worrisome side effects they fear from heavier-duty medications.
You might see “100 mg” stamped on a little pill and not think much of it. Experience tells you, though, that drugs can behave very differently as brands, generics, or from different manufacturers. With doxycycline, consistency in formulation can impact how well a patient tolerates the medicine. Real-world discussions with pharmacists point out that the “monohydrate” and “hyclate” forms behave differently in practice—hyclate usually shows up as a bit harsher on the stomach, for example, a point that matters when a patient feels queasy or hopes to avoid heartburn.
Doxycycline boasts a long half-life, around 18 to 22 hours in most healthy adults, so patients usually take it once or twice daily. This reduces the chances of missed doses, which in turn helps keep treatment effective. I’ve seen patients who do better simply because they don’t have to remember a midday dose, a small but meaningful victory in the challenge of sticking to prescription plans. In the world of antibiotics, keeping things uncomplicated often means better outcomes.
People sometimes think antibiotics only tackle sore throats or sniffles. Doxycycline wears a much wider hat. Beyond the common chest infections and sinus issues, this drug steps up for conditions often overlooked. Travelers, for example, often take doxycycline to prevent malaria in areas where mosquitoes make life a gamble. I’ve spoken to nurses overseas who prefer it to alternatives because, compared to some of the older antimalarials, side effects and resistance are less of a headache.
Specialists see great value in doxycycline’s ability to treat tick-borne diseases like Rocky Mountain spotted fever and ehrlichiosis, which don’t always respond to standard therapies. In the hospital, infectious disease teams lean on it when dealing with “atypical” organisms—bacteria that don’t respond to penicillins or cephalosporins. Its use in sexually transmitted infections, like chlamydia, brings another angle to its story, especially when quick, discreet, and effective options matter for public health.
Doxycycline’s popularity for acne, rosacea, and sometimes even as part of protocols for chronic inflammatory diseases proves it stretches beyond killing bacteria. Dermatologists find its effect on inflammation helps patients who haven’t responded to over-the-counter treatments. It has also made inroads into veterinary care, where its safety profile and dosing range work well for pets with respiratory infections or tick-related illnesses.
Plenty of medications look good in the textbook, but they fall short in the hands of real people. Doxycycline has survived several decades of clinical use, long enough for both its successes and shortcomings to become obvious. While some antibiotics have faded due to resistance or tough side effects, doxycycline sticks around because its balance of power and tolerability holds up across many patient groups.
Hearing firsthand from patients, you learn why some antibiotics are pushed to the back of the cabinet. Gastrointestinal upset can derail a treatment plan quickly. Doxycycline, if taken with enough water and not while lying down, tends to avoid the worst of these problems for most users. Patients who read labels or search online notice the warnings about rare but real risks—phototoxicity, esophageal irritation, or interference with calcium absorption in the developing bones and teeth of children. These aren’t trivial, and doctors address these head-on, adjusting plans for pregnant women or kids under eight.
The medicine’s shelf life and heat stability also help in low-resource settings, an advantage you hear about from relief workers and rural pharmacists. Some antibiotics break down if left outside a refrigerator or during long shipments. Doxycycline manages to remain potent and effective even in warmer climates, keeping people healthy where supply chains falter.
Choosing between antibiotics isn’t just about knocking out germs. It’s about finding what works best for each patient’s life and background. Compared with drugs like azithromycin or amoxicillin, doxycycline stands apart for infections linked to ticks and certain severe respiratory illnesses. Amoxicillin might win for routine ear infections in small children, but experience shows doxycycline outperforms in targeting intracellular organisms, like those seen with some walking pneumonias.
There are also stories of patients who “failed” one antibiotic but began improving shortly after starting doxycycline. That’s why many clinicians reserve it for cases where first-line medications have let patients down, or where lab results hint at a harder-to-treat germ. Doxycycline’s resistance rates, in some corners of the world, stay lower than with older tetracyclines and even some common penicillins—although smart prescribing is more important than ever to keep this edge.
Antibiotic stewardship—using medications only when truly needed—remains a serious concern. Doxycycline, with its broader reach, tempts overuse, which can spur side effects and resistance. In practice, experienced prescribers balance its broad coverage against the nagging risk that bacteria will one day “crack the code.” Still, in hospitals facing outbreaks with limited resources, this medicine’s ability to treat both likely and unlikely organisms can sometimes make the difference.
No drug solves every problem. Doxycycline’s real-world effectiveness owes much to careful use and open communication between patient and provider. Sensitivity to sunlight crops up as a frequent concern—photographs tell the story, with sunburns on cloudy days or after a lunchtime walk. Health professionals now remind patients to use sunscreen and avoid tanning beds, adjusting activity where possible, which helps sidestep uncomfortable rashes. Many who take doxycycline also swap meal times or add more fluids to reduce stomach upset. These practical tips show up in daily conversations at clinics, demonstrating that simple steps matter as much as the science behind the pill.
In the rare case of allergic reaction—a worry with any medicine—patients share stories of hives or swelling. Most people tolerate doxycycline well, yet medical teams keep an eye out for warning signs, especially among those with a long history of allergies. People with liver or kidney disease often stick to regular dosing but benefit from closer follow-up.
Pregnant women and young children face strict guidelines. Doxycycline’s ability to bind calcium and affect bone and tooth development in the young means prescribers pick safer options in these groups. In non-pregnant adults and teens, though, the medicine’s safety portfolio holds up well in studies and experience.
Doxycycline’s story connects to recent outbreaks beyond traditional infections. Public health teams responding to unpredictable threats—like sudden fever spikes in rural Asia or Africa—often stockpile the drug due to its broad spectrum and proven record. During events involving possible Rickettsia exposure, for example after natural disasters or in military deployments, doxycycline’s simplicity and shelf life turn it into a backbone for rapid response protocols.
Travel clinics lean on doxycycline for pre-exposure malaria prevention, often favoring it where resistance makes classic medications less effective. Its easy dosing earns it a nod for travelers who face unfamiliar medical systems abroad. Researchers point to its low cost as a key advantage for developing regions, where price and access make the difference between widespread protection and rising illness.
Even during the COVID-19 pandemic, interest in available antibiotics surged as care teams searched for tools to manage possible bacterial co-infections or treat suspected secondary illnesses. While not meant for viral infections by itself, doxycycline showed up in treatment discussions for patients who developed pneumonia on top of their primary disease.
Antibiotic resistance takes a front seat in conversations with both professionals and patients. Doxycycline, despite its impressive track record, isn’t immune to overuse or careless prescribing. Some bacterial strains now show reduced sensitivity, a sobering reality faced in real time by clinicians in both high-income hospitals and rural community clinics.
Education plays a key role. People who start antibiotics for every cough or sniffle fuel resistance that spreads beyond individual patients. Community outreach, led by pharmacists and doctors who see patterns emerge, has made steady progress in reminding people to use antibiotics only when necessary. Doxycycline, with its high profile and broad use, often becomes the “face” of this message. Stories of recovery, matched by cautionary tales of tough-to-treat superbugs, help drive this lesson home.
Health systems now encourage rapid diagnostics—tests that show in minutes if an infection actually needs antibiotics. Pairing these tools with doxycycline gives clarity for both patients and providers, helping ensure that medicine is only given when it’s likely to do good.
Out-of-pocket cost often drives whether patients finish a prescription or delay treatment. Doxycycline usually comes at a modest price compared to newer, branded antibiotics. This has real meaning for families stretching to pay for care, or in regions where insurance coverage falls short. Low price points, combined with generous shelf lives, have helped get this drug into pharmacies and clinics where newer options never reach.
Pharmacists working in community settings highlight this advantage daily. Many tell stories of helping patients who simply could not afford alternate therapies. Institutions serving uninsured or underinsured populations often choose doxycycline for these reasons—along with the comfort of knowing side effects are manageable without constant medical supervision.
National and international guidelines often mention doxycycline high on their lists for treating specific diseases, both to contain cost and to streamline public health approaches. These recommendations—built from years of evidence and review—help standardize care. Doxycycline’s overlap with multiple lists reinforces its spot as a trusted commodity even as innovation brings new medicines onto the market.
The antibiotic toolbox keeps evolving. While newer agents promise hope for rare, drug-resistant threats, the everyday battles—like a patient with pneumonia or a family facing a tick bite—still lean on reliable staples. Doxycycline remains effective because most doctors and pharmacists respect its power. That means following best practices: prescribing based on clear indications, observing allergies and sensitivities, and educating patients on use.
Industry and health policy makers keep searching for ways to slow antibiotic resistance. Investment in research hints at the future, but most solutions right now rest with healthcare teams and patients. Simple measures—completing the full prescribed course, not sharing pills, not using leftover medicines for unrelated complaints—matter more than the launch of another product line.
Trust in doxycycline comes not just from lab results, but from countless stories of lives improved or illnesses resolved. Global health agencies, front-line doctors, and patients all play a role in writing the ongoing story of this widely used antibiotic. It may not be the flashiest new drug on the shelf, but real-world experience continues to shape how people use and value it every day.